All Q1 FY27 results →
CF

Chambal Fert.

Q1 FY27Fertilizers & Agrochemicals

Chambal Fertilisers & Chemicals Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹426
Market cap₹17.3K Cr
P/E9.0
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

Q2 sales expected to improve due to better monsoon and increased farmer demand (Page 10). Despite current challenges, the company expects long-term growth prospects to remain constructive, supported by a diversified business model and stable operations.

From Chambal Fert.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Moderate growth
  • Q2 sales expected to improve due to better monsoon and increased farmer demand (Page 10).
  • Gradual recovery in fertilizer demand with increased placement post-monsoon (Page 10).
  • NPK production currently low but anticipated support from government subsidy announcements could boost volumes (Page 19).
  • TAN business capacity expansion expected to largely meet domestic demand by FY '28 with strong demand outlook from infrastructure and mining sectors (Page 13).
  • Complex fertilizer volumes tied up with vendors at about 8.5 lakh tons; ongoing efforts to optimize marketing and distribution (Page 14).
  • Ramp-up of Technical Ammonium Nitrate (TAN) project to contribute to growth (Page 5).

2 more points from Chambal Fert.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Chambal Fert. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Chambal Fertilisers is progressing a significant capex with the upcoming granulation plant and new urea plant under the NUP-2026 policy, targeting commissioning by 2030.
  • Preparatory activities for a potential fourth urea plant are ongoing, subject to Board approval.
  • Investments include setting up HDAN capacity (High-Density Ammonium Nitrate) with three products: Weak Nitric Acid, Nitrate Melt, and HDAN.
  • Warehouses are being established to optimize material placement; two nearing completion, one already complete.
  • Financial bids for the new urea plant awaited (expected by mid-October); Board approval pending post-analysis.
  • Considering JV opportunities abroad for phosphatic products.

2 more points from Chambal Fert.'s call on capex

Create a free account to keep reading this call

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chambal Fert. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

It provides relevant insights: - For NPK volumes targeted this year, around 8.5 lakh tons are already tied up with vendors (Page 13). - The sales momentum for fertilizers, including urea and NPK, has improved with significant farmer sales in July (Page 10). - New plant expansions and projects are underway with financial and technical bids expected by mid-October followed by Board approval (Page 6).

Chambal Fert. — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.8K Cr, net profit ₹169 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Rama Phosphates (Q1 FY27)

    Q1 FY27 Revenue from Operations: ₹22,480 Lacs, up 18% YoY from ₹19,031 Lacs in Q1 FY26. Key investor presentation takeaways from Rama Phosphates's Q1 FY27 inves

  • Advance Agrolife (Q1 FY27)

    Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…

  • Bhagiradha Chem. (Q1 FY27)

    195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Sumitomo Chemi. (Q1 FY27)

    1,063.3 crore, a 1% year-on-year (YoY) increase from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q1 FY27 earnings call — and how it ranks…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chambal Fert. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chambal Fert. Q1 FY27 results?

Q2 sales expected to improve due to better monsoon and increased farmer demand (Page 10). Despite current challenges, the company expects long-term growth prospects to remain constructive, supported by a diversified business model and stable operations.

What is Chambal Fert. share price analysis?

Chambal Fert. currently shows a below-average growth signal. The stock trades at a P/E of 9.0 with a market cap of ₹17,274 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chambal Fert. planning capital expenditure?

Chambal Fertilisers is progressing a significant capex with the upcoming granulation plant and new urea plant under the NUP-2026 policy, targeting commissioning by 2030.

Keep Chambal Fert. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.